Murat Ormen

Murat Ormen

Auto-generated profile, based on publicly available information

Murat Ormen

Faculty of Medicine, Department of Clinical Biochemistry , Dokuz Eylul University , Izmir , Türkiye

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2017 in Journal of International Medical Research
Verified
Journal Article
Open access
BDBurcu Serim Demirgoren
Burcu Serim Demirgoren
AOAylin Ozbek
Aylin Ozbek
MOMurat Ormen
Murat Ormen
CKCanem Kavurma
Canem Kavurma
EOEsra Ozer
Esra Ozer
AAAdem Aydin
Adem Aydin
This study aimed to assess the possible association of high breast milk sodium levels with postpartum depression and anxiety. A total of 150 mothers and their healthy, exclusively breastfed newborns aged 8 to 15 days were recruited. Mothers were asked to complete scales for evaluation of postnatal depression and anxiety following an interview for consent and sociodemographic data collection. Breast milk samples were obtained to measure sodium and potassium (K) levels. Forty-nine mothers had higher than expected breast milk Na concentrations and a high Na/K ratio. These mothers scored significantly higher on the scales of postnatal depression and state anxiety (P = 0.018 and P = 0.048, respectively). This study shows that compared to normal breast milk Na levels and Na/K ratio, high breast milk Na and high Na/K ratio, with possible serious consequences in infants, are associated with maternal depressive and anxious symptoms in the postpartum period.

21 November 2023 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
FDFerhat Demirci
Ferhat Demirci
MEMurat EMEÇ
Murat EMEÇ
ODOzlem Gursoy Doruk
Ozlem Gursoy Doruk
MOMurat Ormen
Murat Ormen
PAPINAR AKAN
PINAR AKAN
MOMehmet Hilal Ozcanhan
Mehmet Hilal Ozcanhan
Objectives: Determining low-density lipoprotein (LDL) is a costly and time-consuming operation, but triglyceride value above 400 (TG>400) always requires LDL measurement. Obtaining a fast LDL forecast by accurate prediction can be valuable to experts. However, if a high error margin exists, LDL prediction can be critical and unusable. Our objective is LDL value and level prediction with an error less than low total acceptable error rate (% TEa). Methods: Our present work used 6392 lab records to predict the patient LDL value using state-of-the-art Artificial Intelligence methods. The designed model, p-LDL-M, predicts LDL value and class with an overall average test score of 98.70 %, using custom, hyper-parameter-tuned Ensemble Machine Learning algorithm. Results: The results show that using our innovative p-LDL-M is advisable for subjects with critical TG>400. Analysis proved that our model is positively affected by the Hopkins and Friedewald equations normally used for (TG≤400). The conclusion follows that the test score performance of p-LDL-M using only (TG>400) is 7.72 % inferior to the same p-LDL-M, using Hopkins and Friedewald supported data. In addition, the test score performance of the NIH-Equ-2 for (TG>400) is much inferior to p-LDL-M prediction results. Conclusions: In conclusion, obtaining an accurate and fast LDL value and level forecast for people with (TG>400) using our innovative p-LDL-M is highly recommendable.

1 June 2023 in Nigerian Journal of Clinical Practice
Verified
Journal Article
Open access
MÖM Örmen
M Örmen
ÖDÖg Doruk
Ög Doruk
HGH Gözgöz
H Gözgöz
AKA Kutlu
A Kutlu
GNG Nurcan
G Nurcan
PTP Tuncel
P Tuncel
Background: In COVID-19 patients, besides changes in leucocyte count, morphological abnormalities of circulating blood cells have been reported. Aim: This study aims to investigate the relationship between the morphological and functional properties of leucocytes and the severity of the disease in COVID-19 patients. Materials and Methods: Blood samples were collected from COVID-19 patients (n = 130) at the time of admission. The patients were stratified according to the comorbidity, age, LDH, lymhocyte count score as mild, moderate, and severe. Complete blood count and the cell population data were analyzed by the Volume, conductivity, scatter (VCS) technology on Beckman Coulter LH-780 hematology analyzer. Kruskal–Wal`lis test was used to assess the differences between the groups with subsequent Bonferroni correction. Results: Neutrophil count was increased, and lymphocyte count was decreased in severe patients compared to mild patients. The increase in the percent of neutrophils and the neutrophil/lymphocyte ratio in the severe patient group was significant in comparison to both the moderate and the mild group. The dispersion of the neutrophil volume and conductivity showed significant changes depending on the severity of the disease. The lymphocyte volume, lymphocyte-volume-SD and lymphocyte-conductivity as well as the monocyte-volume and monocyte-volume-SD were significantly increased in severe patients in comparison to mild patients. The increase of lymphocyte and monocyte volume in severe patients was also significant in comparison to moderate patients. Conclusions: COVID-19 infection leads to important changes in cell population data of leucocytes. The volumetric changes in lymphocytes and monocytes are related to the severity of the disease.

3 October 2025 in Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
ÖDÖzlem Gürsoy Doruk
Özlem Gürsoy Doruk
SUSezer Uysal
Sezer Uysal
HGHazar Gözgöz
Hazar Gözgöz
BGBurak Gündoğdu
Burak Gündoğdu
MÖMurat Örmen
Murat Örmen
CÇCanan Çoker
Canan Çoker
Objectives: Ensuring result comparability across identical analyzers is critical in high-throughput clinical laboratories. ISO 15189:2022 emphasizes this requirement (clause 7.3.7.4), particularly for assays with low within-subject biological variation (BV), where reference intervals may be insufficient to detect clinically relevant changes. Methods: This study aimed to implement a practical rule-based approach for evaluating result consistency across identical analyzers using only internal quality control (IQC) data. At Dokuz Eylul University Central Laboratory (DEU-CL), IQC results from two Beckman Coulter AU5800 and two UniCel DxI 800 analyzers were collected over 12 months (May 2022–April 2023). Coefficient of variation (CV) and bias were calculated from the first five consecutive working days of each month. Total error (TE) was computed using the RMS method (TE=Bias + 1.65 × CV) and compared to total allowable error (TEa) limits defined by the EFLM BV database and Rili-BAEK guideline. Results: Among the 20 parameters evaluated, blood urea nitrogen (BUN), C-reactive protein (CRP), direct/total bilirubin, triglycerides, and uric acid consistently met EFLM TEa criteria. In contrast, albumin, creatinine, sodium, and total protein frequently exceeded EFLM limits. Sodium exhibited persistent nonconformities across all months. Most parameters fulfilled Rili-BAEK specifications. Conclusions: The proposed model enables continuous monthly performance assessment of identical analyzers using only routine IQC data. This approach supports ISO 15189:2022 compliance, facilitates early detection of analytical discrepancies, and may serve as an efficient, cost-effective quality assurance tool for high-volume laboratories.